| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/26/2004 | EP1422242A1 Plastic and elastic protein copolymers |
| 05/26/2004 | EP1422241A1 Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 05/26/2004 | EP1422240A2 Analogs of nociceptin |
| 05/26/2004 | EP1422239A2 Mobilization of hematopoietic stem cells using a chemokine |
| 05/26/2004 | EP1422238A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 05/26/2004 | EP1422237A2 Methods for the recombinant production of antifusogenic peptides |
| 05/26/2004 | EP1422213A1 Process for producing optically active halopropanediol derivative |
| 05/26/2004 | EP1421951A2 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/26/2004 | EP1421948A2 Use of botulinum toxins for treating sweating in humans |
| 05/26/2004 | EP1421947A1 p53 vaccine |
| 05/26/2004 | EP1421946A1 A pharmaceutical being used for treating hiv infection, the composition and uses thereof |
| 05/26/2004 | EP1421539A2 Stabilized proteins with engineered disulfide bonds |
| 05/26/2004 | EP1421391A2 Sodium channel regulators and modulators |
| 05/26/2004 | EP1421390A2 Mammalian diabetes-mediating proteins |
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421385A1 Genetic construct intracellular monitoring system |
| 05/26/2004 | EP1421379A2 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421222A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 05/26/2004 | EP1421214A2 Amplified oncogenes and their involvement in cancer |
| 05/26/2004 | EP1421208A2 Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof |
| 05/26/2004 | EP1421207A2 Method for the detection of cytochrome b mutations in fungi |
| 05/26/2004 | EP1421199A2 Compositions and methods for treating neurodegenerative diseases |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1421196A2 Rice regulatory sequences for gene expression in defined wheat tissue |
| 05/26/2004 | EP1421190A2 Metabolic gene polynucleotides and polypeptides and uses thereof |
| 05/26/2004 | EP1421188A1 Methods to increase the productivity of heterologous gene expression |
| 05/26/2004 | EP1421184A2 Live attenuated strains of prrs virus |
| 05/26/2004 | EP1421183A2 Methods for improving seed and grain characteristics |
| 05/26/2004 | EP1421177A2 Zinc finger binding domains for cnn |
| 05/26/2004 | EP1421176A2 Nucleic acids and encoded polypeptides associated with bipolar disorder |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421117A2 Compositions and methods for generating chimeric heteromultimers |
| 05/26/2004 | EP1421116A2 Vaccine therapies and prophylactic treatments of atherosclerotic diseases |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |
| 05/26/2004 | EP1421114A1 Chimeric g protein coupled receptors |
| 05/26/2004 | EP1421113A1 Methods of screening based on the egf receptor crystal structure |
| 05/26/2004 | EP1421112A1 Novel serine protease |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421110A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton |
| 05/26/2004 | EP1421108A2 Antimicrobial and anti-inflammatory peptides |
| 05/26/2004 | EP1421104A2 Human zona pellucida proteins and methods of their use in diagnosing male infertility |
| 05/26/2004 | EP1421103A2 Method for making acylated polypeptides |
| 05/26/2004 | EP1421102A2 Method for making acylated polypeptides |
| 05/26/2004 | EP1421101A2 P-glycoproteins and uses thereof |
| 05/26/2004 | EP1421098A2 Surface proteins of streptococcus pyogenes |
| 05/26/2004 | EP1421096A2 CONSTITUTIVE PHOTOMORPHOGENESIS 1 (COP1) NUCLEIC ACID SEQUENCE FROM i ZEA MAYS /i AND ITS USE THEREOF |
| 05/26/2004 | EP1420821A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/26/2004 | EP1420820A2 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
| 05/26/2004 | EP1420819A1 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 05/26/2004 | EP1420817A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 05/26/2004 | EP1420816A2 Uses of mammalian cytokine; related reagents |
| 05/26/2004 | EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine |
| 05/26/2004 | EP1420814A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/26/2004 | EP1420811A2 Method and composition for prophylaxis of diabetes |
| 05/26/2004 | EP1420810A1 Modulation of leukocyte-endothelial interactions following ischemia |
| 05/26/2004 | EP1420807A1 Platelet-derived growth factor protection of cardiac myocardium |
| 05/26/2004 | EP1420806A2 Triple polypeptide complexes |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420646A1 Antimicrobial agent |
| 05/26/2004 | EP1420637A2 Transgenic rodents as animal models for modulation of b 1? bradykinin receptor protein |
| 05/26/2004 | EP1420635A1 Development of transgenic model for interventions in neurodegenerative diseases |
| 05/26/2004 | EP1420631A1 Plant-derived resistance gene |
| 05/26/2004 | EP1420630A2 Stress-related polynucleotides and polypeptides in plants |
| 05/26/2004 | EP1389123A4 A non-lethal method for extracting crude hemocyanin from gastropod molluscs |
| 05/26/2004 | EP1196443B1 Erythropoietin conjugates with polyethylenglycol |
| 05/26/2004 | EP1104475B1 C-myc is activated by beta-catenin and tcf-4 |
| 05/26/2004 | EP1083927B1 HUMAN MINOR VAULT PROTEIN p193 |
| 05/26/2004 | EP1056465A4 Antimicrobial peptides and derived metapeptides |
| 05/26/2004 | EP0995121B1 C-peptide specific assay procedure |
| 05/26/2004 | EP0977838B1 H2-o modified transgenic animals |
| 05/26/2004 | EP0969851B1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 05/26/2004 | EP0929300B1 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 05/26/2004 | EP0812331B1 Mhc-antigen complexes for detecting and purifying antigen-specific t cells |
| 05/26/2004 | EP0751781B1 Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic disorders |
| 05/26/2004 | EP0744959B1 Treatment of antibiotic associated diarrhea |
| 05/26/2004 | EP0728217B1 Nucleic acid mutation detection by analysis of sputum |
| 05/26/2004 | CN1500152A Nucleic acid vaccines for prevention of flavivirus infection |
| 05/26/2004 | CN1500145A Method for sectetion and prodn. of protein |
| 05/26/2004 | CN1500142A High level cytokine prodn. with enhanced cell viability |
| 05/26/2004 | CN1500096A Osteoprotegerin in milk |
| 05/26/2004 | CN1500095A Polymer conjugates of neublastin and methods of using ssame |
| 05/26/2004 | CN1499982A Use of Il-18 inhibitors for treatment and/or prevention of heart disease |
| 05/26/2004 | CN1499979A Compsns. contg active fraction isolates from hedyotis diffusae and methods of use |
| 05/26/2004 | CN1498963A Method for producing virus like granules of human papilloma virus |
| 05/26/2004 | CN1498901A Artificial hirudinoid proteinase chalone as well coded gene and method for expressing gene in high efficiency |
| 05/26/2004 | CN1498900A Anticoagulation protein of artificial threadworm as well as coding gene and method for expressing it in high efficiency |
| 05/26/2004 | CN1498899A Vegetable protein as well as preparation method and application |
| 05/26/2004 | CN1151377C Method of diagnosing and treating epithelioma |
| 05/26/2004 | CN1151376C Application of combined antigen for african lymphocytoma virus to test serum reactions of nasopharyngeal cancer patient before and after treatment |
| 05/26/2004 | CN1151263C Overxpression of desired proteins in eukaryotic cells mediated by cyclin D1 overexpression |
| 05/26/2004 | CN1151262C Method for expression of foreign genes and vectors therefor |
| 05/26/2004 | CN1151259C Human UMP_CMP kinase and its coding sequence, preparing process |
| 05/26/2004 | CN1151258C Prodn. of erythropoietin by endogenous gene activation |
| 05/26/2004 | CN1151254C Structure and purification of venin-class thrombase for preventing and curing thrombotic diseases |
| 05/26/2004 | CN1151173C Production process of neurotrophic factor |
| 05/26/2004 | CN1151172C Novel membrane proteine P76 of helicobacter pylori |
| 05/26/2004 | CN1151171C Recombinant syphilis spirochete epitope antigen and multiple-epitope chmeric |
| 05/26/2004 | CN1151170C Isolated peptides derived from MAGE tumor rejection antigen precursops which complex with HLA-A2 molecules |
| 05/26/2004 | CA2450504A1 Csrc polynucleotides and uses thereof for biofilm modulation |